<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03823664</url>
  </required_header>
  <id_info>
    <org_study_id>GO 17/793</org_study_id>
    <nct_id>NCT03823664</nct_id>
  </id_info>
  <brief_title>Cardiorespiratory Fitness in Prediabetic,Type 2 Diabetic and Healthy Individuals</brief_title>
  <official_title>Assesment of Cardiorespiratory Fitness in Prediabetic,Type 2 Diabetic and Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study to investigate and compare cardiorespiratory fitness (CRF) parameters
      of prediabetic, type 2 diabetic and healthy individuals. CRF assessed with cardiopulmonary
      exercise test (CPET) which is gold standard measure of CRF. Pulmonary functions,
      inflammation, disease specific parameters such as HbA1c, fasting plasma glucose etc affect
      CRF in prediabetic and type 2 diabetics.All parameters examine in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be participated with Type 2 diabetic,prediabetic and healthy patients.
      Patients' laboratory values, pulmonary function test, respiratory muscle strength, exercise
      capacity, physical activity level, quality of life, cardiorespiratory fitness levels will
      assess and record. Pulmonary function test will be assesed with CPET system, respiratory
      muscle strength will be evaluated with mouth pressure. Exercise capacity will be evaluated
      using six minute walking test, incremental shuttle walk test. And cardiorespiratory fitness
      will assess CPET system. Physical activity level will be evaluated trial accelerometer and
      International Physical Activity Questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Actual">June 25, 2020</completion_date>
  <primary_completion_date type="Actual">June 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiorespiratory fitness</measure>
    <time_frame>November 2018-August 2019</time_frame>
    <description>Refers to the ability of the circulatory and respiratory systems to supply oxygen to skeletal muscles during sustained physical exercise. It will be evaluated with Cardiopulmonary Exercise Test (CPET,CPX) System</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Exercise Capacity</measure>
    <time_frame>December 2018-August 2019</time_frame>
    <description>6 Minutes Walk Test's distance, meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary functions</measure>
    <time_frame>December 2018-August 209</time_frame>
    <description>Forced expiratory volume in first second (FEV1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Muscle Strength</measure>
    <time_frame>December 2018-August 2019</time_frame>
    <description>Mouth pressures; maximal inspiratory and expiratory pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Exercise Capacity</measure>
    <time_frame>December 2018-August 2019</time_frame>
    <description>İncremental Shuttle Walk Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Level</measure>
    <time_frame>December 2018-August 2019</time_frame>
    <description>Accelerometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary functions</measure>
    <time_frame>December 2018-August 2019</time_frame>
    <description>Forced vital capacity (FVC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary functions</measure>
    <time_frame>December 2018-August 2019</time_frame>
    <description>Peak expiratory flow (PEF)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Prediabetic State</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Cardiorespiratory Fitness</condition>
  <condition>Inflammation</condition>
  <condition>Exercise Test</condition>
  <arm_group>
    <arm_group_label>Type 2 Diabetic</arm_group_label>
    <description>Fasting Plasma Glucose ≥126 mg/dL (7.0 mmol/L). OR * A1C ≥6.5% (48 mmol/mol). OR * Patients with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥200 mg/dL (11.1 mmol/L).OR* 2-h Plasma Glucose ≥200 mg/dL (11.1 mmol/L) during oral glucose tolerance test*
* American Diabetes As. (ADA) type 2 diabetes diagnosis criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prediabetic</arm_group_label>
    <description>Fasting Plasma Glucose 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (Impaired Fasting Glucose)* OR A1C 5.7-6.4% (39-47 mmol/mol)* OR 2-h Plasma Glucose during 75-g Oral Glucose Tolerance Test 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (Impaired Glucose Tolerance)*
* ADA prediabetes criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy glucose metabolism and according to endocrinology visit no health problems related or affect cardiorespiratory fitness and other parameters examined in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiorespiratory Fitness</intervention_name>
    <description>Maximal symptom limited cardiopulmonary exercise test used assessment of cardiorespiratory fitness. For pulmonary function spirometry test and maximal respiratory pressures assessed.</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Prediabetic</arm_group_label>
    <arm_group_label>Type 2 Diabetic</arm_group_label>
    <other_name>Exercise capacity</other_name>
    <other_name>Pulmonary function</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Type 2 diabetic patients -&gt; Type 2 diabetes diagnosed population, Prediabetic -&gt; According
        to ADA criteria persons in prediabetic condition Healthy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cooperation,

          -  No assistance for Ambulation,

          -  Body Mass Index&lt;40

          -  Diagnose of prediabetes/type 2 diabetes and health

        Exclusion Criteria:

          -  Any cardiac problems,

          -  Uncontrolled hypertension,

          -  Any neurologic disease,

          -  Uncontrolled diabetes,

          -  Any orthopedic disease impairs walking, balance

          -  Any respiratory disease affects cardiorespiratory fitness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebru Calik-Kutukcu, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hulya Arikan, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cemile Bozdemir-Ozel, MsC</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Selcuk Dagdelen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beyza Nur Karaduz, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hacettepe University</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 8, 2018</study_first_submitted>
  <study_first_submitted_qc>January 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2019</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Beyza Karadüz</investigator_full_name>
    <investigator_title>Physiotherapist</investigator_title>
  </responsible_party>
  <keyword>prediabetes</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>cardiorespiratory fitness</keyword>
  <keyword>pulmonary functions</keyword>
  <keyword>functional capacity</keyword>
  <keyword>exercise capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

